{
  "id": "0b28733ecb635472",
  "title": "What if Oprah Knew About Fractyl Health ? ",
  "description": "People like Oprah Winfrey have struggled to maintain their weight loss after weaning themselves off GLP-1s. What if an outpatient medtech procedure did the trick?",
  "content": "![scale weight loss](https://medcitynews.com/wp-content/uploads/sites/7/2024/12/GettyImages-sb10068935i-001.jpg)\n\nOprah Winfrey [recently revealed](https://people.com/oprah-reveals-she-stopped-using-glp1s-for-12-months-and-shares-exactly-what-happened-exclusive-11877163) that when she stopped taking her GLP-1 medications, she gained 20 pounds in 12 months. She thought she could maintain the weight loss by diet and exercise alone, and chose to wean herself off the drugs so that she would not be dependent on them. But once she regained the weight, she realized that she couldn\u2019t battle obesity without some help. She is now taking the medications again.\n\nLooks like Winfrey could be the perfect target candidate for [Fractyl Health](https://medcitynews.com/tag/fractyl-health/), a medical device company that is running clinical trials for an outpatient procedure to help people who want to get off GLP-1s without regaining all the weight.\n\n\u201cThe unmet need is shifting heavily towards solving this post-GLP-1 weight regain problem,\u201d said Harith Rajagopalan, co-founder and CEO of the Burlington, Massachusetts-based medtech company, in a recent interview in San Francisco.\n\npresented by\n\n![](https://medcitynews.com/wp-content/uploads/sites/7/2025/12/Esperion-logo-cropped-1024x206.png)\n\n[Sponsored Post](https://medcitynews.com/category/sponsored-post/)\n\n[![](https://medcitynews.com/wp-content/uploads/sites/7/2025/12/sheldon_koenig_feature_thumbnail-360x200.jpg)](https://medcitynews.com/2026/01/esperion-sets-its-sights-on-new-areas-while-maintaining-commitment-to-cardiovascular-health/)\n\n### [Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health](https://medcitynews.com/2026/01/esperion-sets-its-sights-on-new-areas-while-maintaining-commitment-to-cardiovascular-health/)\n\nIn a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company\u2019s expansion into new diseases\n\n[By Esperion](http",
  "source": "medcitynews.com",
  "source_url": "https://medcitynews.com/2026/01/what-if-oprah-knew-about-fractyl-health/",
  "published_at": "20260130T013000Z",
  "fetched_at": "2026-01-31T00:26:46.418942+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://medcitynews.com/2026/01/what-if-oprah-knew-about-fractyl-health/",
    "url_mobile": "",
    "title": "What if Oprah Knew About Fractyl Health ? ",
    "seendate": "20260130T013000Z",
    "socialimage": "https://medcitynews.com/wp-content/uploads/sites/7/2024/12/GettyImages-sb10068935i-001.jpg",
    "domain": "medcitynews.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}